Stock PFE PFIZER, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Pfizer, Inc.

Equities

PFE

US7170811035

Market Closed - Nyse
Other stock markets
 04:01:34 2024-04-29 pm EDT 		Pre-market 09:15:48 am
25.64 USD +0.94% Intraday chart for Pfizer, Inc. 25.72 +0.29%
02:52pm Sensodyne maker Haleon to shut UK factory with loss of 435 jobs AN
05:55am Genmab, Pfizer Win US FDA Approval for Cervical Cancer Treatment MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
BU
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
BU
Novel haemophilia B gene therapy approved
AQ
Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting
BU
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
BU
Pfizer Declares Second-Quarter 2024 Dividend
BU
Pfizer : Political Action Committee (PAC) Report
PU
Second Circuit Rules That Associational Standing For A Preliminary Injunction Requires Identifying At Least One Injured Member By Name
AQ
Big pharma giants in English High Court for global Covid dispute
AQ
European Commission Approves Pfizer's EMBLAVEO for Patients with Multidrug-Resistant Infections and Limited Treatment Options
AQ
European Commission approves novel antibiotic
AQ
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
BU
Skanska announces decreased scope for facility in Everett, Washington, USA, worth USD 49M, about SEK 510M
AQ
University of Oregon: Options can lower vaccine hesitancy for COVID-19, other diseases
AQ
Skanska announces decreased scope for facility in Everett, Washington, USA, worth USD 49M, about SEK 510M
AQ
Pfizer : January 2023 – December 2023
PU
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
BU
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO in Adults Aged 18 to 59 at Increased Risk for RSV Disease
AQ
Pfizer : March Social Media Round-Up—Annual Review, International Women’s Day, and a School of Science Celebration
PU
Tempus Releases New Data at AACR Showcasing Ways to Analyze Multimodal Data to Highlight Potential Therapeutic Routes for HER2- Directed Antibody-Drug Conjugates in Several Tumor Types
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PFE Stock
  4. News Pfizer, Inc.
  5. Press Releases